Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Artificial synthesized insulin-simulated peptide and its application

A technology of artificial synthesis and insulin, applied in the direction of medical preparations containing active ingredients, peptides, drug combinations, etc., can solve the problems of high synthesis cost and difficulty in synthesis, and achieve the effect of low preparation cost, high product purity and easy synthesis

Inactive Publication Date: 2008-02-27
ZHEJIANG UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Since the insulin molecule contains A and B double-chain structures (the A chain consists of 21 amino acids, and the B chain consists of 30 amino acids), there is a problem of correct pairing of disulfide bonds between the double chains, and the synthesis is usually difficult and costly.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Artificial synthesized insulin-simulated peptide and its application
  • Artificial synthesized insulin-simulated peptide and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Example 1: Using anti-insulin polyclonal antibody as target protein, screening phage 9 peptide library by phage display method (Ph.D.-C7C TM ) to obtain positive phage clones

[0015] The phage display method uses genetic engineering to clone a set of synthetic oligonucleotide fragments of a certain length and random sequence into a specific expression vector, so that the expression product is presented on the surface of filamentous phage in the form of fusion protein. Since the peptide library contains all possible amino acid sequences of small peptides of this length or most of them, each phage presents one of the peptides, so the library has a large capacity and is easy to screen and amplify. Infect E. coli with the phage peptide library, and the random oligonucleotide fragments recombined into the phage are replicated in E. coli and expressed in the coat protein of the phage. Then, coat the target protein on the microtiter plate. After mixing the phage peptide lib...

Embodiment 2

[0018] Embodiment 2: Cell competitive ELISA test

[0019] Test method: HepG2 cells were cultured to the logarithmic growth phase, and the same amount was inoculated into 96-well cell culture plates. After 24 hours, wash twice with PBS, fix with 10% Formalin-PBS for 15min, wash three times with PBS, and wash with 3% H 2 o 2 Treat for 10min. Wash 3 times with PBS, block with 2% BSA for 1 hour at 37°C, wash 3 times with PBST, add 10 -9 Insulin M, acted at 37°C for 90 minutes. After washing with PBST for 3 times, small peptides of different concentrations were added, and the cells were competed at 37°C for 90 minutes. Wash 3 times with PBST, incubate with primary antibody at 37°C for 1 hour, wash with PBST 5 times, add secondary antibody and incubate at 37°C for 1 hour. After washing 5 times with PBST and 1 time with PBS, the color was developed, and the absorbance (OD) at a wavelength of 450 nm was read by a microplate reader. 450 ). In the experiment, blank wells and posi...

Embodiment 3

[0021] Example 3: Effects of Mimic Peptides on Blood Glucose in Normal ICR Mice

[0022] Test method: 30 normal ICR mice were randomly divided into normal control group (10 mice), insulin control group (10 mice) and insulin mimetic peptide treatment group (10 mice). The mice in each experimental group were marked separately, and after fasting for 12 hours, the fasting blood glucose was measured. The mice in the insulin mimetic peptide treatment group were injected with 100 μl of 1 mg / ml peptide solution (prepared in 0.9% normal saline), and the insulin control group was injected with 2 U / kg. For insulin, the normal control group was injected with an equal volume of 0.9% normal saline. Blood was collected 45 minutes after the injection, the blood glucose was measured by the o-toluidine method, and the changes of blood glucose before and after the injection were compared.

[0023] Test results: the results are shown in Figure 2, which shows the effect of the insulin mimetic pep...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The provided water-soluble polypeptide compound belonged to synthetic insulin mimetic peptide comprises nine amino acids of a and b types connected with each other by peptide bond, can combine with insulin antibody and specific the insulin acceptor in body to produce hypoglycemic effect to replace the insulin for diabetic treatment, and can be composed more easily than the double-bond insulin with low cost and high purity.

Description

technical field [0001] The invention belongs to organic compounds and relates to chemically synthesized polypeptides, in particular to artificially synthesized insulin mimetic peptides and applications thereof. Background technique [0002] Protein is an important class of biomacromolecules in the body, but it has inherent disadvantages when used as a drug for the treatment of diseases, such as large molecular weight, difficult preparation, and high antigenicity. The study of small peptides that retain the biologically active sites of proteins has become a hot spot. These small peptides can overcome the problems in production and use to a certain extent, and they are another way to develop drugs. [0003] As early as 1986, Geysen believed that short peptides containing key residues can mimic the determinants on proteins; in most cases, the interaction or recognition between proteins is achieved through the interaction between local peptides. The binding of insulin to its re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/06A61K38/08A61P3/10
Inventor 詹金彪裘锋平
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com